ProcureCon Pharma 2020

17 - 18 March, 2020

Hotel Palace Berlin, Germany

44 (0) 207 368 9465

  • img
  • img

2018 Whitepapers and Content

Best Practices for Successful Merger Integration in the Pharmaceutical and Biomedical Space - Sodexo

Best Practices for Successful Merger Integration in the Pharmaceutical and Biomedical Space - Sodexo

The U.S. pharmaceutical and biomedical sectors are experiencing a period of tumultuous mergers and acquisitions (M&A) as companies face pressures from financial investors to increase growth, and a changing healthcare system is shaping new business models. But many mergers often fail, largely because of sharp cultural differences in the merged companies.

An M&A must be well planned if its full value is to be achieved. Extensive research and experience have shown that effective integration requires top leadership to drive the transformation. A common vision and good plan are essential, communication with all stakeholders is a must, and cultural differences must be understood and managed.

With the extensive M&A activity breaking apart and recreating pharmaceutical and biomedical companies, we are seeing the future pharmaceutical company emerge.

Pharma company gets a strong dose of procurement excellence - Agile1

Pharma company gets a strong dose of procurement excellence - Agile1

While globalisation has opened the doors for companies to expand their businesses across borders into new markets, these growth opportunities come with certain challenges.

Procurement Healthcare Challenges

Procurement Healthcare Challenges

In the current economic climate, Pharma companies are under growing pressure: companies have lost billions of dollars in annual revenue due to patents coming to an end, and have seen their market share eroded by cheaper generic drugs. As a result, some procurement organisations are facing severe

cost cutting measures.
Addressing these challenges is central to the role procurement plays within the business. 
In light of this we surveyed 100 healthcare procurement professionals from companies across Europe to find out their opinions on topics such as how to measure performance within procurement, the level of visibility over risk in the supply chain and the biggest problems faced when entering new markets.
Expert Roundup 2018

Expert Roundup 2018

We asked the experts from AstraZeneca, Bayer, Lonza and UBC to answer to some of the most pressing questions senior pharma procurement professionals are thinking at the moment. Read the exclusive article to find out how they see procurement playing a strategic role in the digitisation of their organisations, what are they doing to take business partnering to the next level and what new approaches are you they to unlock even more innovation from your supplier base.
Pharma Procurement Performs - ProcureCon Pharma Report

Pharma Procurement Performs - ProcureCon Pharma Report

This survey was distributed to healthcare procurement professionals from companies across Europe to find out their opinions on topics such as how to measure performance within Procurement, the level of visibility over risk in the supply chain and the biggest problems faced when entering new markets. The goal of the survey was to understand where today’s healthcare procurement teams stand on some of the current issues facing the marketplace. Read the report and make the most of this unique opportunity to compare your priorities and challenges compared to those of your peers.